Thrombectomy Linked to Lower Pulmonary Embolism Mortality
A meta-analysis of 12 studies links mechanical thrombectomy to lower mortality than anticoagulation alone in intermediate-risk pulmonary embolism.
Updated on Nov. 2, 2026 in Stroke
A systematic review and meta-analysis of 12 studies involving 4,268 patients found that mechanical thrombectomy was associated with lower 30-day, one-year and two-year mortality than anticoagulation alone in intermediate-risk pulmonary embolism. The findings were presented at TCT 2026 and published in JSCAI.
Why it matters
Intermediate-risk pulmonary embolism is a serious condition, and the findings suggest mechanical thrombectomy may offer a survival advantage over standard anticoagulation. Because most of the evidence is observational, the results remain preliminary.
The meta-analysis pooled 12 studies covering 4,268 patients, of whom 1,878 (44%) received mechanical thrombectomy versus anticoagulation alone. A sensitivity analysis limited to intermediate-risk-only studies found similar 30-day mortality between groups, and one- and two-year mortality could not be pooled because each was reported by a single study.
The details
Researchers analyzed the pooled data and found lower 30-day, one-year and two-year mortality with mechanical thrombectomy, along with a lower risk of chronic thromboembolic pulmonary hypertension. Most of the available evidence is observational, and larger randomized trials are needed to confirm the findings and identify which patients benefit most.
Timeline
Findings were presented at TCT 2026 and published in JSCAI on November 2, 2026.
Health Landscape
This meta-analysis adds to a growing body of observational evidence on catheter-based treatment of pulmonary embolism, which has yet to be confirmed in randomized trials. Until larger randomized studies report, anticoagulation alone remains the comparator against which mechanical thrombectomy is being evaluated.
For patients with intermediate-risk pulmonary embolism, the findings suggest mechanical thrombectomy may be worth discussing with clinicians alongside anticoagulation. Treatment decisions should rest on individual clinical assessment, as randomized evidence is still pending.
The takeaway
Mechanical thrombectomy showed a survival association in pooled data, but randomized trials are needed before it becomes a standard recommendation. Patients should discuss the evidence and their individual risk with their care team.
Further reading
Explore more on Stroke for related context on vascular clot treatment.
Source note: This article includes information reported by Azertag.
